Telmisartan, ramipril, or both in patients at high risk for vascular events
Donald G. VidtVolume:
10
Language:
english
Pages:
2
DOI:
10.1007/s11906-008-0064-4
Date:
October, 2008
File:
PDF, 142 KB
english, 2008